Literature DB >> 9972119

Long-term sub-antimicrobial doxycycline (Periostat) as adjunctive management in adult periodontitis: effects on subgingival bacterial population dynamics.

J G Thomas1, R J Metheny, J M Karakiozis, J M Wetzel, R J Crout.   

Abstract

Previous trials had indicated that various schedules of sub-antimicrobial doxycycline significantly reduced gingival crevicular fluid (GCF) collagenase activity in adult patients with periodontitis with no evidence of emergent tetracycline-resistant (Tcr) marker oral flora. The purpose of this nine-month study was to expand these observations, emphasizing newer microbial diagnostic methods. Subgingival paper point samples were obtained at baseline (BL), 3, 6, and 9 months. Four subject treatment groups in a double-blind design were evaluated by mechanical scaling and root planing (SRP) and/or 20 mg doxycycline BID (Periostat). Thirty-eight patients entered the study at baseline (BL). Dark-field microscopy on 260 samples showed that morphotype distribution was independent of treatment schedule. Culture analysis of the 3 most prevalent isolates recovered showed that Streptococcus and Prevotella species accounted for approximately 85% of the 724 cultures. There did not appear to be any overgrowth or replacement by opportunistic oral flora. Of 658 susceptibility patterns evaluated by Etest, the MIC50/90 and mode MIC showed stable patterns, independent of treatment group. Our findings were different from those of previously published reports, but may be partly explained by the lack of universally standardized methods in oral microbiology and interpretive criteria for susceptibility testing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9972119     DOI: 10.1177/08959374980120011601

Source DB:  PubMed          Journal:  Adv Dent Res        ISSN: 0895-9374


  5 in total

Review 1.  Challenges of repurposing tetracyclines for the treatment of Alzheimer's and Parkinson's disease.

Authors:  Iva Markulin; Marija Matasin; Viktorija Erdeljic Turk; Melita Salković-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2022-01-04       Impact factor: 3.850

2.  Subantimicrobial dose doxycycline effects on osteopenic bone loss: microbiologic results.

Authors:  Clay Walker; Susan Puumala; Lorne M Golub; Julie A Stoner; Richard A Reinhardt; Hsi-Ming Lee; Jeffrey B Payne
Journal:  J Periodontol       Date:  2007-08       Impact factor: 6.993

3.  Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis.

Authors:  Mehrdokht Mazdeh; Ahmad Reza Mobaien
Journal:  Iran J Neurol       Date:  2012

4.  The effect of doxycycline on canine hip osteoarthritis: design of a 6-months clinical trial.

Authors:  Korakot Nganvongpanit; Peraphan Pothacharoen; Niyada Suwankong; Siriwan Ong-Chai; Prachya Kongtawelert
Journal:  J Vet Sci       Date:  2009-09       Impact factor: 1.672

5.  Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine.

Authors:  Ying Gu; Clay Walker; Maria E Ryan; Jeffrey B Payne; Lorne M Golub
Journal:  J Oral Microbiol       Date:  2012-10-12       Impact factor: 5.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.